AKT1 and cancer: BMS-754807 suppresses PI3K/AKT/mTOR downstream of IR/IGF-1R, thus sensitizing cancer cells to CP (Figure 2 and Figure 3) and potentially increasing autophagic flux through suppression of mTOR.